GH Research PLC (GHRS)
NASDAQ: GHRS · Real-Time Price · USD
28.23
+0.31 (1.11%)
At close: Sep 4, 2026, 4:00 PM EDT
28.30
+0.07 (0.25%)
After-hours: Sep 4, 2026, 7:30 PM EDT
GH Research Earnings Call Transcripts
Fiscal Year 2025
-
GH001 showed rapid, robust, and sustained efficacy in TRD, with a high remission rate and favorable safety profile. Long-term data indicate durable remission with infrequent treatments and fewer clinic visits compared to current standards.